A. Isowaki

In Vivo/In Vitro Correlation of Intravitreal Drug Delivery from Biodegradable Polymer Implants

K. Tojo, H. Aoyagi, A. Isowaki, 2002 .

Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate.

Makiko Yamamoto, Shin-ichi Yasueda, A. Isowaki, 2005, International journal of pharmaceutics.

A method for synthesis of fluorine compounds using abnormal Grignard reaction of halothane. II: Reaction with aldehydes and unsaturated ketones

T. Takagi, A. Isowaki, A. Ando, 1995 .

Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid.

H. Takeuchi, K. Tojo, N. Ohguro, 2009, Biological & pharmaceutical bulletin.

Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.

H. Sakaki, A. Isowaki, T. Tajika, 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Metabolic profiles of difluprednate in rabbit ocular tissues after instillation of difluprednate ophthalmic emulsion

H. Sakaki, A. Isowaki, T. Tajika, 2010, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery.

K. Tojo, A. Isowaki, 2001, Advanced drug delivery reviews.